Trials / Unknown
UnknownNCT05361161
Transarterial Chemoembolization With Lipiodol in the Treatment of Initial Unresectable Gastric Cancer (GC)
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Gang Wu · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, open-labelled study to evaluate the efficacy and safety of sequential transarterial chemoembolization with lipiodol and neoadjuvant chemotherapy in the treatment of Initial unresectable gastric cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Transarterial Chemoembolization | Arterial infusion chemotherapy (THP + oxaliplatin + raltitrexed) and THP combined with lipiodol embolization for 2 times, with an interval of 1 month. |
Timeline
- Start date
- 2022-06-01
- Primary completion
- 2022-12-01
- Completion
- 2025-12-01
- First posted
- 2022-05-04
- Last updated
- 2022-05-24
Source: ClinicalTrials.gov record NCT05361161. Inclusion in this directory is not an endorsement.